Document 0530 DOCN M9440530 TI HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions. DT 9404 AU Lima ES; Bastos FI; Telles PR; Friedman SR; Nucleo de Estudos e Pesquisas em Atencao ao Uso de Drogas,; University of Rio de Janeiro, Brazil. SO Bull Narc. 1993;45(1):107-15. Unique Identifier : AIDSLINE MED/94138311 AB Data from various countries show considerable variation in the rate of spread of the human immunodeficiency virus (HIV) among drug injectors. Although further research is needed to predict the rate of increase of seroprevalence at Rio de Janeiro, preliminary data confirm the presence of the virus, with a seroprevalence of about 33 per cent in 1990. Issues arising from research into the probable determinants of viral spread among the thousands of drug injectors in the city are outlined in the present paper. Even before the research is completed, however, it is clear that interventions are needed to reduce further viral transmission both among drug injectors and from them to their sexual partners and offspring. Efforts should be made to prevent the population at risk from initiating the practice of drug injection, and to promote a major expansion in drug abuse treatment facilities. Drug injectors should also be encouraged to reduce the risk of their becoming infected or passing on the virus to others, through educational outreach, through the distribution of supplies that facilitate risk reduction (bleach, syringes, condoms), and through innovative approaches to behaviour change. DE Acquired Immunodeficiency Syndrome/*EPIDEMIOLOGY/*ETIOLOGY/ PREVENTION & CONTROL/TRANSMISSION Brazil/EPIDEMIOLOGY Condoms Disinfection Forecasting Health Behavior Human HIV Infections/*EPIDEMIOLOGY/*ETIOLOGY/PREVENTION & CONTROL/ TRANSMISSION *HIV Seroprevalence Needles Patient Education *Population Surveillance Public Health Administration Research Risk Factors Substance Abuse Treatment Centers Substance Abuse, Intravenous/*COMPLICATIONS/PREVENTION & CONTROL Urban Population JOURNAL ARTICLE REVIEW REVIEW LITERATURE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).